The Effect of Podcast Education on Postpartum Depression, Maternal Attachment, and Self-Care Agency in the Early Postpartum Period: A Randomized Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age19+
SponsorSaglik Bilimleri Universitesi

About this trial

The population of the study, planned as a randomized controlled experimental design, consists of primiparous women who gave birth in the delivery unit of Istanbul Esenler Women's Health and Pediatric Diseases Hospital. The sample of the study will be composed of 110 postpartum women who meet the sampling criteria, are willing to participate, and are determined by power analysis. The study includes two groups: the "intervention group (n=55)," who will receive discharge education through podcasts in the early postpartum period, and the "control group (n=55)," who will receive routine discharge education. Women in the intervention group will listen to four podcasts, each lasting 5-6 minutes, about discharge education during the early postpartum period. Before the data collection forms are applied, participants will be asked to complete an "Informed Consent Form." All groups will be evaluated with the "Edinburgh Postpartum Depression Scale," the "Maternal Attachment Scale," and the "Self-Care Agency Scale" both before and after the intervention. The discussion and conclusions of the study will be written based on the results obtained.

Eligibility criteria

Qualifiers

Volunteering to participate in the study

Being primigravida

Being over the age of 19

Giving birth in the delivery unit of Esenler Maternity and Children's Hospital

Disqualifiers

Unwillingness to participate in the study

Having a psychiatric diagnosis and/or using psychiatric medication

Being an adolescent mother

Being a high-risk postpartum woman

Trial design

Treatments tested in this trial

  • Providing discharge education via podcasts

Treatment groups

110 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators